Our team

Head of Regulatory Strategy & Drug Development Cliician

Kirsty is a clinician and expert medical assessor with extensive experience of regulation in clinical trials and more than a decade’s experience at the MHRA.

Senior Drug Development Clinician

Dominique is a physician scientist and university professor with extensive hands-on experience of strategic drug hunting and drug development in pharma and academia.

Head of Clinical Operations

Geoff has worked at a senior level on trials Phases I to IV on a variety of international projects involving therapeutic agents ranging from small molecules to gene therapy, and is highly regarded for his success in leading R&D teams.

Senior Drug Development Clinician

Arash is a clinician scientist with broad experience in drug development, including target discovery, early phase clinical trial design, Mendelian/rare disorders, oligonucleotide therapeutics, CV, oncology, drug repositioning and novel platform/precision medicine approaches.

Senior Drug Development Clinician

Raj is a company creation executive and commercial and technical due diligence professional who brings extensive experience of asset and unmet need analyses, competitor therapy area pipeline investigations, and indication selection therapeutic area mapping.

Senior Drug Development Clinician

Jagtaris a physician scientist with a decade of clinical expertise in rheumatology and experience in translational medicine, developing innovative end-to-end clinical plans and influencing translational biology plans using deep disease expertise and biomarker-rich approaches.

Senior Drug Development Clinician

Michael is a physician-scientist and oncologist with extensive experience of translational medicine and conducting trials from FIH to PIII, including for compounds with Breakthrough Therapy and Innovate Licensing and Access Pathway designations.

Senior Clinical Pharmacologist

Simon is an expert in pre-clinical and clinical pharmacology who has advised, designed, managed and delivered multiple FIH and POC studies across many therapeutic areas, including oncology, inflammation and infectious diseases.

Drug Development Clinician

Harriet is a paediatrician with expertise primarily in oncology. Her PhD investigated cancer drivers and synthetic lethality in osteosarcoma. She founded and chairs PCD Research, a medical research charity.

Senior Drug Development Statistician

Margaret is a leading statistician with more than 20 years' experience in industry. She brings extensive delivery experience of adaptive trial designs, biomarker strategies, globally harmonised approaches, and implementing industry data standards.

Regulatory Expert

Mark is an experienced executive with 30+ years’ industry experience who brings in-depth knowledge of US, Europe, and Japanese drug development and regulatory requirements supporting MAAs, INDs, CTAs, Pediatric Study and Investigational Plans, Fast Track Designation, RMAT Designation, BTD, Accelerated Approval (US), Accelerated Assessment (EU), ODD, and Japan Sakigake Designation.​

Regulatory Expert

Juliet is a pharmaceutical physician with over 25 years’ experience in clinical development and the regulatory aspects of clinical trials. A former medical assessor at the MHRA, Juliet brings deep knowledge across all phases of drug development, from first-in-human trials through to license application. ​​

Senior Safety and Pharmacovigilance Consultant

Mary is a highly experienced pharmacovigilance and patient safety expert with more than 25 years of experience across pharma. Formerly SVP, Head of Patient Safety at UCB Pharma, she occupied multiple senior positions at UCB across twelve years..

Associate Consultant

Ryan is a clinician with experience across therapeutic areas including oncology and respiratory medicine. He gained his medical degree from the University of Oxford during which he gained experience in molecular medicine and undertook research in multiple myeloma.​

Strategic Advisor

Koki is an is an experienced commercial executive and pharmaceutical physician with a track record of leading and managing business units as S/VP, supervising sales, marketing, and product communication in addition to launching new products and evaluating in-licensing opportunities.

Early Drug Development Scientist

Tim is an experienced chief scientific officer with a track record of delivering on small molecule, biologics, and new chemical (NCE) project as well as successful biotech deals and partnerships.

Drug Development Clinician

Matthew is a prizewinning neuroscientist and doctor with a decade of research experience in functional neuroimaging, computational cognitive neuroscience, and neuropsychopharmacology.

Drug Development Statistician

Hakim is a specialist in the design and analysis of clinical trials, providing critical input to creation, design and delivery of pioneering drug development programmes across all clinical trial phases, therapeutic and disease areas.

Strategy Director

Sneha is a health tech professional with more than 12 years’ experience of scaling tech-enabled approaches in healthcare across a range of platforms including AI, corporate strategy, and commercialisation in drug development.

Strategy Director

Strategy and business development executive, Steven has led multiple therapeutic landscape assessments across clinical and commercial stage assets, using the inputs to support business development and support R&D strategy.

Strategy Consultant

Freddie is a UCL and Francis Crick oncology PhD and former grants adviser in infection and immunobiology at the Wellcome Trust working across clinical development, strategy and business development.

Strategy Analyst

Alex has a BSc Hons in Biomedical Sciences from The University of Edinburgh, where he focused on Bioinformatics, Biomedical data science, Global Health, Genomics, Immunology, and Pharmacology.

Clinical Operations Director

Debbie is a highly experienced clinical operations director with extensive expertise across the full life cycle of clinical trials management, including paediatric and pilot studies.

Clinical Operations Project Manager

Eulene is a clinical research professional with more than thirty years’ experience of clinical operations, and fifteen years managing Phase I-IV clinical trials Worldwide and Europe in particular.

Clinical Operations Project Manager

Luca is a multilingual study manager and full clinical trial lifecycle management professional with more than 18 years’ experience of setting up and managing single and multi-centre studies across all phases (including PIP and observational studies), patient populations, centres, geographical locations and a broad range of therapeutic areas.

Clinical Operations Project Manager

Jeremy has over 20 years’ experience in pharma and brings an impressive record in planning, setting up, coordinating, managing and overseeing every aspect of early phase clinical trials both nationally and globally.

Clinical Operations Director

Harj has a significant track record of designing, managing and leading international and multi-centre studies through all phases; setting up clinical development teams; developing study protocols; and devising clinical development plans and study timelines.

Drug Development Analyst

Zuhair was a BBSRC scholar at UCL’s Drug Discovery Lab, where he recently completed his PhD. He specialises in computational, biophysical and cell biology methods in immune-oncology and brings expertise in experimental pharmacology and genetic, cellular and molecular biology.

Drug Development Analyst

Pharmacology graduate knowledgeable in bioinformatics approaches, Katie has researched in multiple therapeutic areas including neuroscience, cardiovascular, and inflammation, and has previous operational experience working in a biomanufacturing and medical diagnostics company.

Drug Development Analyst

Laurel has a PhD in Bioinformatics and Biological sciences and MSc in Neuroscience. She has a specialist interest in implementing descriptive, diagnostic, and predictive models of patterns and molecular signatures in biomedical data, networks using disease module enrichment and advanced statistical and computational data analysis.

Information Governance Consultant

Russell is a records management and information governance professional with extensive experience of selection, evaluation and implementation of archives and procedures, including metadata schema and digital preservation.

Pharmacologist

Neil is a research scientist with more than 20 years experience working in large pharmaceutical companies specialised in applied modelling and simulation, PKPD, and QSP.

Clinical Pharmacologist

Graham is a pharmacist and clinical pharmacologist of more than 30 years’ experience with extensive knowledge of translational science and significant track record of completing programs from candidate selection through FIH and PoC to submission and approval.

Operations Director

Victoria is a project and product manager with extensive experience with SMEs in the banking sector, where she executed multiple complex projects in regulatory and compliance, feasibility, communications, and marketing.

Events Manager

Caroline brings substantial experience of working internationally in the production of small- and large-scale events to budget and with finesse, incorporating summits, incentive programmes, sales kick-off meetings, scientific advisory boards, and leadership events.

Finance and Operations Analyst

Armin is a charity trustee and trainee chartered governance professional. He co-headed an early career development initiative developed with the University of St Andrews and is a past fellow of the Royal Society of Arts.